Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Fractures

  Free Subscription


Articles published in Osteoporos Int

Retrieve available abstracts of 350 articles:
HTML format
Text format



Single Articles


    May 2017
  1. ABDERHALDEN L, Weaver FM, Bethel M, Demirtas H, et al
    Response to Sabour: Dual-energy X-ray absorptiometry and fracture prediction in patients with spinal cord injuries and disorders: methodological issues.
    Osteoporos Int. 2017 May 15. doi: 10.1007/s00198-017-4056.
    PubMed     Text format    


  2. SABOUR S
    Dual-energy X-ray absorptiometry and fracture prediction in patients with spinal cord injuries and disorders: methodological issues.
    Osteoporos Int. 2017 May 13. doi: 10.1007/s00198-017-3990.
    PubMed     Text format    


  3. GULIN T, Kruljac I, Kirigin Bilos LS, Gulin M, et al
    The role of adipokines as prognostic factors of one-year mortality in hip fracture patients.
    Osteoporos Int. 2017 May 13. doi: 10.1007/s00198-017-4068.
    PubMed     Text format     Abstract available


  4. YIN P, Lv H, Li Y, Meng Y, et al
    The association between serum uric acid level and the risk of fractures: a systematic review and meta-analysis.
    Osteoporos Int. 2017 May 9. doi: 10.1007/s00198-017-4059.
    PubMed     Text format     Abstract available


  5. LIN YC, Huang TS, Wu JS, Cheung YC, et al
    Are bilateral decubitus views necessary in assessing for vertebral compression fractures using DXA vertebral fracture assessment?
    Osteoporos Int. 2017 May 9. doi: 10.1007/s00198-017-4040.
    PubMed     Text format     Abstract available


  6. BOGL HP, Aspenberg P, Schilcher J
    Undisturbed local bone formation capacity in patients with atypical femoral fractures: a case series.
    Osteoporos Int. 2017 May 4. doi: 10.1007/s00198-017-4058.
    PubMed     Text format     Abstract available


  7. MALGO F, Hamdy NAT, Papapoulos SE, Appelman-Dijkstra NM, et al
    Bone material strength index as measured by impact microindentation is low in patients with fractures irrespective of fracture site.
    Osteoporos Int. 2017 May 2. doi: 10.1007/s00198-017-4054.
    PubMed     Text format     Abstract available


    April 2017
  8. DOMBROWSKI S, Kostev K, Jacob L
    Use of dipeptidyl peptidase-4 inhibitors and risk of bone fracture in patients with type 2 diabetes in Germany-A retrospective analysis of real-world data.
    Osteoporos Int. 2017 Apr 29. doi: 10.1007/s00198-017-4051.
    PubMed     Text format     Abstract available


  9. KANIS JA, Cooper C, Rizzoli R, Abrahamsen B, et al
    Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting.
    Osteoporos Int. 2017 Apr 27. doi: 10.1007/s00198-017-4009.
    PubMed     Text format     Abstract available


  10. MCCLOSKEY EV
    Identification of vertebral fractures: a moderately severe solution?
    Osteoporos Int. 2017 Apr 27. doi: 10.1007/s00198-017-4042.
    PubMed     Text format    


  11. BERRY SD, Zullo AR, McConeghy K, Lee Y, et al
    Defining hip fracture with claims data: outpatient and provider claims matter.
    Osteoporos Int. 2017 Apr 26. doi: 10.1007/s00198-017-4008.
    PubMed     Text format     Abstract available


  12. LI C, Zeng Y, Tao L, Liu S, et al
    Meta-analysis of hypertension and osteoporotic fracture risk in women and men.
    Osteoporos Int. 2017 Apr 26. doi: 10.1007/s00198-017-4050.
    PubMed     Text format     Abstract available


  13. CLARK EM, Cummings SR, Schousboe JT
    Spinal radiographs in those with back pain-when are they appropriate to diagnose vertebral fractures?
    Osteoporos Int. 2017 Apr 25. doi: 10.1007/s00198-017-4052.
    PubMed     Text format     Abstract available


  14. MOBERG L, Nilsson PM, Samsioe G, Sallsten G, et al
    Increased blood cadmium levels were not associated with increased fracture risk but with increased total mortality in women: the Malmo Diet and Cancer Study.
    Osteoporos Int. 2017 Apr 21. doi: 10.1007/s00198-017-4047.
    PubMed     Text format     Abstract available


  15. DOMBROWSKI S, Jacob L, Hadji P, Kostev K, et al
    Oral contraceptive use and fracture risk-a retrospective study of 12,970 women in the UK.
    Osteoporos Int. 2017 Apr 13. doi: 10.1007/s00198-017-4036.
    PubMed     Text format     Abstract available


  16. SATO H, Kondo N, Nakatsue T, Wada Y, et al
    High and pointed type of femoral localized reaction frequently extends to complete and incomplete atypical femoral fracture in patients with autoimmune diseases on long-term glucocorticoids and bisphosphonates.
    Osteoporos Int. 2017 Apr 13. doi: 10.1007/s00198-017-4038.
    PubMed     Text format     Abstract available


  17. YAN J, Liu HJ, Li H, Chen L, et al
    Circulating periostin levels increase in association with bone density loss and healing progression during the early phase of hip fracture in Chinese older women.
    Osteoporos Int. 2017 Apr 5. doi: 10.1007/s00198-017-4034.
    PubMed     Text format     Abstract available


  18. BARDAI G, Ward LM, Trejo P, Moffatt P, et al
    Molecular diagnosis in children with fractures but no extraskeletal signs of osteogenesis imperfecta.
    Osteoporos Int. 2017 Apr 4. doi: 10.1007/s00198-017-4031.
    PubMed     Text format     Abstract available


  19. HUNG YC, Lin CC, Chen HJ, Chang MP, et al
    Severe hypoglycemia and hip fracture in patients with type 2 diabetes: a nationwide population-based cohort study.
    Osteoporos Int. 2017 Apr 3. doi: 10.1007/s00198-017-4021.
    PubMed     Text format     Abstract available


    March 2017
  20. PETIT M-, Bryere J, Maravic M, Pallaro F, et al
    Hip fracture incidence and social deprivation: results from a French ecological study.
    Osteoporos Int. 2017 Mar 23. doi: 10.1007/s00198-017-3998.
    PubMed     Text format     Abstract available


  21. CHEN YY, Feng JY, Ting WY, Yen YF, et al
    Increased risk of incident osteoporosis and osteoporotic fracture in tuberculosis patients: a population-based study in a tuberculosis-endemic area.
    Osteoporos Int. 2017 Mar 22. doi: 10.1007/s00198-017-3939.
    PubMed     Text format     Abstract available


  22. THOMPSON MJ, Aitken DA, Otahal P, Cicolini J, et al
    The relationship between cumulative lifetime ultraviolet radiation exposure, bone mineral density, falls risk and fractures in older adults.
    Osteoporos Int. 2017 Mar 20. doi: 10.1007/s00198-017-4001.
    PubMed     Text format     Abstract available


  23. MOHD-TAHIR NA, Li SC
    Economic burden of osteoporosis-related hip fracture in Asia: a systematic review.
    Osteoporos Int. 2017 Mar 17. doi: 10.1007/s00198-017-3985.
    PubMed     Text format     Abstract available


  24. MAHARLOUEI N, Atefi S, Namazi H, Kazemifar S, et al
    The incidence of hip fracture in Shiraz, Iran: a promising rate comparing to previous studies.
    Osteoporos Int. 2017 Mar 16. doi: 10.1007/s00198-017-3983.
    PubMed     Text format     Abstract available


  25. MAJUMDAR SR, Lier DA, Hanley DA, Juby AG, et al
    Economic evaluation of a population-based osteoporosis intervention for outpatients with non-traumatic non-hip fractures: the "Catch a Break" 1i [type C] FLS.
    Osteoporos Int. 2017 Mar 9. doi: 10.1007/s00198-017-3986.
    PubMed     Text format     Abstract available


  26. IMAI T, Tanaka S, Kawakami K, Miyazaki T, et al
    Health state utility values and patient-reported outcomes before and after vertebral and non-vertebral fractures in an osteoporosis clinical trial.
    Osteoporos Int. 2017 Mar 6. doi: 10.1007/s00198-017-3966.
    PubMed     Text format     Abstract available


  27. WEI Y, Tian W, Zhang GL, Lv YW, et al
    Thoracolumbar kyphosis is associated with compressive vertebral fracture in postmenopausal women.
    Osteoporos Int. 2017 Mar 1. doi: 10.1007/s00198-017-3971.
    PubMed     Text format     Abstract available


    February 2017
  28. MERLE B, Chapurlat R, Vignot E, Thomas T, et al
    Post-fracture care: do we need to educate patients rather than doctors? The PREVOST randomized controlled trial.
    Osteoporos Int. 2017 Feb 28. doi: 10.1007/s00198-017-3953.
    PubMed     Text format     Abstract available


  29. NARDONE V, Tini P, Carbone SF, Grassi A, et al
    Bone texture analysis using CT-simulation scans to individuate risk parameters for radiation-induced insufficiency fractures.
    Osteoporos Int. 2017 Feb 27. doi: 10.1007/s00198-017-3968.
    PubMed     Text format     Abstract available


  30. TAMAKI J, Iki M, Sato Y, Kajita E, et al
    Total 25-hydroxyvitamin D levels predict fracture risk: results from the 15-year follow-up of the Japanese Population-based Osteoporosis (JPOS) Cohort Study.
    Osteoporos Int. 2017 Feb 27. doi: 10.1007/s00198-017-3967.
    PubMed     Text format     Abstract available


  31. ROUX C, Briot K
    Imminent fracture risk.
    Osteoporos Int. 2017 Feb 24. doi: 10.1007/s00198-017-3976.
    PubMed     Text format     Abstract available


  32. LEE SH, Hsu WT, Lai CC, Esmaily-Fard A, et al
    Erratum to: Use of antipsychotics increases the risk of fracture: a systematic review and meta-analysis.
    Osteoporos Int. 2017 Feb 23. doi: 10.1007/s00198-017-3938.
    PubMed     Text format    


  33. FENG Y, Cheng G, Wang H, Chen B, et al
    The associations between serum 25-hydroxyvitamin D level and the risk of total fracture and hip fracture.
    Osteoporos Int. 2017 Feb 20. doi: 10.1007/s00198-017-3955.
    PubMed     Text format     Abstract available


  34. UNGPRASERT P, Crowson CS, Matteson EL
    Risk of fragility fracture among patients with sarcoidosis: a population-based study 1976-2013.
    Osteoporos Int. 2017 Feb 16. doi: 10.1007/s00198-017-3962.
    PubMed     Text format     Abstract available


  35. DEDE AD, Trovas G, Chronopoulos E, Triantafyllopoulos IK, et al
    Response to: A role for thiazide diuretic therapy in preventing bone loss, fracture and nephrolithiasis in individuals with thalassemia and hypercalciuria?
    Osteoporos Int. 2017 Feb 13. doi: 10.1007/s00198-017-3927.
    PubMed     Text format    


  36. MORTON A
    A role for thiazide diuretic therapy in preventing bone loss, fracture, and nephrolithiasis in individuals with thalassemia and hypercalciuria?
    Osteoporos Int. 2017 Feb 13. doi: 10.1007/s00198-017-3922.
    PubMed     Text format    


  37. COSMAN F, Krege JH, Looker AC, Schousboe JT, et al
    Spine fracture prevalence in a nationally representative sample of US women and men aged >/=40 years: results from the National Health and Nutrition Examination Survey (NHANES) 2013-2014.
    Osteoporos Int. 2017 Feb 7. doi: 10.1007/s00198-017-3948.
    PubMed     Text format     Abstract available


  38. HARVEY NC, McCloskey EV, Mitchell PJ, Dawson-Hughes B, et al
    Mind the (treatment) gap: a global perspective on current and future strategies for prevention of fragility fractures.
    Osteoporos Int. 2017 Feb 7. doi: 10.1007/s00198-016-3894.
    PubMed     Text format     Abstract available


  39. BALLANE G, Cauley JA, Luckey MM, El-Hajj Fuleihan G, et al
    Worldwide prevalence and incidence of osteoporotic vertebral fractures.
    Osteoporos Int. 2017 Feb 6. doi: 10.1007/s00198-017-3909.
    PubMed     Text format     Abstract available


  40. LESPESSAILLES E, Cortet B, Legrand E, Guggenbuhl P, et al
    Low-trauma fractures without osteoporosis.
    Osteoporos Int. 2017 Feb 4. doi: 10.1007/s00198-017-3921.
    PubMed     Text format     Abstract available


  41. PADRON-MONEDERO A, Lopez-Cuadrado T, Galan I, Martinez-Sanchez EV, et al
    Effect of comorbidities on the association between age and hospital mortality after fall-related hip fracture in elderly patients.
    Osteoporos Int. 2017 Feb 3. doi: 10.1007/s00198-017-3926.
    PubMed     Text format     Abstract available


  42. MIKULA AL, Hetzel SJ, Binkley N, Anderson PA, et al
    Validity of height loss as a predictor for prevalent vertebral fractures, low bone mineral density, and vitamin D deficiency.
    Osteoporos Int. 2017 Feb 3. doi: 10.1007/s00198-017-3937.
    PubMed     Text format     Abstract available


  43. CARBONE LD, Buzkova P, Fink HA, Robbins JA, et al
    Association of DPP-4 activity with BMD, body composition, and incident hip fracture: the Cardiovascular Health Study.
    Osteoporos Int. 2017 Feb 2. doi: 10.1007/s00198-017-3916.
    PubMed     Text format     Abstract available


  44. LANDI F, Calvani R, Ortolani E, Salini S, et al
    The association between sarcopenia and functional outcomes among older patients with hip fracture undergoing in-hospital rehabilitation.
    Osteoporos Int. 2017 Feb 2. doi: 10.1007/s00198-017-3929.
    PubMed     Text format     Abstract available


    January 2017
  45. MUSCHITZ C, Kocijan R, Baierl A, Dormann R, et al
    Preceding and subsequent high- and low-trauma fracture patterns-a 13-year epidemiological study in females and males in Austria.
    Osteoporos Int. 2017 Jan 30. doi: 10.1007/s00198-017-3925.
    PubMed     Text format     Abstract available


  46. LEE SH, Hsu WT, Lai CC, Amin EF, et al
    Use of antipsychotics increases the risk of fracture: a systematic review and meta-analysis.
    Osteoporos Int. 2017 Jan 12. doi: 10.1007/s00198-016-3881.
    PubMed     Text format     Abstract available


  47. BROZEK W, Reichardt B, Zwerina J, Dimai HP, et al
    Use of proton pump inhibitors and mortality after hip fracture in a nationwide study.
    Osteoporos Int. 2017 Jan 12. doi: 10.1007/s00198-017-3910.
    PubMed     Text format     Abstract available


  48. AYUS JC, Bellido T, Negri AL
    Hyponatremia and fractures: should hyponatremia be further studied as a potential biochemical risk factor to be included in FRAX algorithms?
    Osteoporos Int. 2017 Jan 10. doi: 10.1007/s00198-017-3907.
    PubMed     Text format     Abstract available


  49. FUNG TT, Meyer HE, Willett WC, Feskanich D, et al
    Protein intake and risk of hip fractures in postmenopausal women and men age 50 and older.
    Osteoporos Int. 2017 Jan 10. doi: 10.1007/s00198-016-3898.
    PubMed     Text format     Abstract available


    December 2016
  50. BURGE RT, Disch DP, Gelwicks S, Zhang X, et al
    Hip and other fragility fracture incidence in real-world teriparatide-treated patients in the United States.
    Osteoporos Int. 2016 Dec 27. doi: 10.1007/s00198-016-3888.
    PubMed     Text format     Abstract available


  51. JOHANSSON H, Siggeirsdottir K, Harvey NC, Oden A, et al
    Imminent risk of fracture after fracture.
    Osteoporos Int. 2016 Dec 27. doi: 10.1007/s00198-016-3868.
    PubMed     Text format     Abstract available


  52. ROGERS TS, Blackwell TL, Lane NE, Tranah G, et al
    Rest-activity patterns and falls and fractures in older men.
    Osteoporos Int. 2016 Dec 24. doi: 10.1007/s00198-016-3874.
    PubMed     Text format     Abstract available


  53. BARRO V, Nunez JH, Gargallo-Margarit A, Sallent A, et al
    Bilateral insufficiency hip fractures after bariatric surgery.
    Osteoporos Int. 2016 Dec 23. doi: 10.1007/s00198-016-3889.
    PubMed     Text format     Abstract available


  54. FECHTENBAUM J, Kolta S, Briot K, Roux C, et al
    Vertebral fracture assessment by dual X-ray absorptiometry.
    Osteoporos Int. 2016.
    PubMed     Text format    


  55. RUD B, Hyldstrup L
    Vertebral fracture assessment by dual X-ray absorptiometry: reply to comments by Fechtenbaum et al.
    Osteoporos Int. 2016.
    PubMed     Text format    


  56. ABDERHALDEN L, Weaver FM, Bethel M, Demirtas H, et al
    Dual-energy X-ray absorptiometry and fracture prediction in patients with spinal cord injuries and disorders.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  57. CIRNIGLIARO CM, Myslinski MJ, La Fountaine MF, Kirshblum SC, et al
    Bone loss at the distal femur and proximal tibia in persons with spinal cord injury: imaging approaches, risk of fracture, and potential treatment options.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  58. KRISTENSEN PK, Thillemann TM, Pedersen AB, Soballe K, et al
    Socioeconomic inequality in clinical outcome among hip fracture patients: a nationwide cohort study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


    November 2016
  59. LAU TW, Fang C, Leung F
    The effectiveness of a multidisciplinary hip fracture care model in improving the clinical outcome and the average cost of manpower.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  60. JACOB L, Kostev K
    Impact of attention deficit hyperactivity disorder therapy on fracture risk in children treated in German pediatric practices.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  61. SAEZ-LOPEZ P, Branas F, Sanchez-Hernandez N, Alonso-Garcia N, et al
    Hip fracture registries: utility, description, and comparison.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  62. SANCHEZ A, Blanco R
    Osteonecrosis of the jaw (ONJ) and atypical femoral fracture (AFF) in an osteoporotic patient chronically treated with bisphosphonates.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  63. KIM H, Baek KH, Lee SY, Ahn SH, et al
    Association of circulating dipeptidyl-peptidase 4 levels with osteoporotic fracture in postmenopausal women.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  64. PEDERSEN AB, Gammelager H, Kahlert J, Sorensen HT, et al
    Impact of body mass index on risk of acute kidney injury and mortality in elderly patients undergoing hip fracture surgery.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  65. WU TY, Hu HY, Lin SY, Chie WC, et al
    Trends in hip fracture rates in Taiwan: a nationwide study from 1996 to 2010.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  66. KRUSE C, Eiken P, Vestergaard P
    Clinical fracture risk evaluated by hierarchical agglomerative clustering.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  67. RAY R, Clement ND, Aitken SA, McQueen MM, et al
    High mortality in younger patients with major osteoporotic fractures.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  68. CHEN FP, Shyu YC, Fu TS, Sun CC, et al
    Secular trends in incidence and recurrence rates of hip fracture: a nationwide population-based study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  69. MATHAVAN N, Tagil M, Isaksson H
    Do osteoporotic fractures constitute a greater recalcitrant challenge for skeletal regeneration? Investigating the efficacy of BMP-7 and zoledronate treatment of diaphyseal fractures in an open fracture osteoporotic rat model.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  70. SHAH A, Prieto-Alhambra D, Hawley S, Delmestri A, et al
    Geographic variation in secondary fracture prevention after a hip fracture during 1999-2013: a UK study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


    October 2016
  71. SUMREIN BO, Huttunen TT, Launonen AP, Berg HE, et al
    Proximal humeral fractures in Sweden-a registry-based study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  72. MA J, McMillan HJ, Karaguzel G, Goodin C, et al
    The time to and determinants of first fractures in boys with Duchenne muscular dystrophy.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  73. ADAMS AL, Xue F, Chantra JQ, Dell RM, et al
    Sensitivity and specificity of radiographic characteristics in atypical femoral fractures.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  74. BEATON DE, Vidmar M, Pitzul KB, Sujic R, et al
    Addition of a fracture risk assessment to a coordinator's role improved treatment rates within 6 months of screening in a fragility fracture screening program.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  75. FINK HA, Litwack-Harrison S, Taylor BC, Bauer DC, et al
    Erratum to: Clinical utility of routine laboratory testing to identify possible secondary causes in older men with osteoporosis: the osteoporotic fractures in men (MrOS) study.
    Osteoporos Int. 2016.
    PubMed     Text format    


  76. HILIGSMANN M, Burlet N, Fardellone P, Al-Daghri N, et al
    Public health impact and economic evaluation of vitamin D-fortified dairy products for fracture prevention in France.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  77. IKI M, Fujita Y, Tamaki J, Kouda K, et al
    Incident fracture associated with increased risk of mortality even after adjusting for frailty status in elderly Japanese men: the Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) Cohort Study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  78. SCHOUSBOE JT, Paudel ML, Taylor BC, Kats AM, et al
    Pre-fracture individual characteristics associated with high total health care costs after hip fracture.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  79. MORI T, Crandall CJ, Ganz DA
    Cost-effectiveness of combined oral bisphosphonate therapy and falls prevention exercise for fracture prevention in the USA.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  80. SU Y, Leung J, Hans D, Aubry-Rozier B, et al
    Added clinical use of trabecular bone score to BMD for major osteoporotic fracture prediction in older Chinese people: the Mr. OS and Ms. OS cohort study in Hong Kong.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  81. KLOP C, van Staa TP, Cooper C, Harvey NC, et al
    The epidemiology of mortality after fracture in England: variation by age, sex, time, geographic location, and ethnicity.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  82. WALLACE ER, Siscovick DS, Sitlani CM, Dublin S, et al
    Incident atrial fibrillation and the risk of fracture in the cardiovascular health study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  83. SOLBAKKEN SM, Meyer HE, Stigum H, Sogaard AJ, et al
    Excess mortality following hip fracture: impact of self-perceived health, smoking, and body mass index. A NOREPOS study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  84. RUGGIERO C, Bonamassa L, Pelini L, Prioletta I, et al
    Early post-surgical cognitive dysfunction is a risk factor for mortality among hip fracture hospitalized older persons.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  85. MORIWAKI K, Noto S
    Economic evaluation of osteoporosis liaison service for secondary fracture prevention in postmenopausal osteoporosis patients with previous hip fracture in Japan.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


    September 2016
  86. ATTERITANO M, Di Mauro E, Canale V, Bruzzese AM, et al
    Higher serum sclerostin levels and insufficiency of vitamin D are strongly associated with vertebral fractures in hemodialysis patients: a case control study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  87. CHEN J, Smerdely P
    Hypocalcaemia after denosumab in older people following fracture.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  88. SMALLWOOD AJ, Schapira MM, Fedders M, Neuner JM, et al
    A pilot randomized controlled trial of a decision aid with tailored fracture risk tool delivered via a patient portal.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  89. ROSENGREN BE, Bjork J, Cooper C, Abrahamsen B, et al
    Recent hip fracture trends in Sweden and Denmark with age-period-cohort effects.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  90. AVENELL A, Bolland MJ, Grey A, Reid IR, et al
    Further major uncorrected errors in National Osteoporosis Foundation meta-analyses of calcium and vitamin D supplementation in fracture prevention.
    Osteoporos Int. 2016.
    PubMed     Text format    


  91. BALOGH R, Wood J, Dobranowski K, Lin E, et al
    Low-trauma fractures and bone mineral density testing in adults with and without intellectual and developmental disabilities: a population study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  92. AUBRY-ROZIER B, Fabreguet I, Iglesias K, Lamy O, et al
    Impact of level of expertise versus the statistical tool on vertebral fracture assessment (VFA) readings in cohort studies.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  93. PEREIRA L, Bliuc D, Stanford P, Eisman JA, et al
    More-than-minimal-trauma fractures are associated with low bone density: an 8-year prospective study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  94. VALA CH, Oden A, Lorentzon M, Sundh V, et al
    Increased risk of hip fracture among spouses-evidence of a homogamy effect.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


    August 2016
  95. TAKAHASHI S, Hoshino M, Takayama K, Iseki K, et al
    Time course of osteoporotic vertebral fractures by magnetic resonance imaging using a simple classification: a multicenter prospective cohort study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  96. DUAN X, Wang J, Jiang X
    A meta-analysis of breastfeeding and osteoporotic fracture risk in the females.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  97. SU Y, Leung J, Hans D, Lamy O, et al
    The added value of trabecular bone score to FRAX(R) to predict major osteoporotic fractures for clinical use in Chinese older people: the Mr. OS and Ms. OS cohort study in Hong Kong.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  98. TRINH A, Wong P, Brown J, Hennel S, et al
    Fractures in spina bifida from childhood to young adulthood.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  99. BUCHELE G, Becker C, Cameron ID, Auer R, et al
    Fracture risk in people with developmental disabilities: results of a large claims data analysis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  100. POONURU S, Findling JW, Shaker JL
    Lower extremity insufficiency fractures: an underappreciated manifestation of endogenous Cushing's syndrome.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  101. CLARK E
    Health-related quality of life in older people with osteoporotic vertebral fractures: response to comments by Sani et al.
    Osteoporos Int. 2016.
    PubMed     Text format    


  102. SANI M, Ayubi E, Khazaei S, Mansori K, et al
    Health-related quality of life in older people with osteoporotic vertebral fractures: clinically important vs. statistically significant.
    Osteoporos Int. 2016.
    PubMed     Text format    


  103. ROTONDI NK, Beaton DE, Ilieff M, Adhihetty C, et al
    The impact of fragility fractures on work and characteristics associated with time to return to work.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


    July 2016
  104. HANSEN L, Petersen KD, Eriksen SA, Gerstoft F, et al
    Subjects with osteoporosis to remain at high risk for fracture despite benefit of prior bisphosphonate treatment-a Danish case-control study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  105. KYVERNITAKIS I, Kostev K, Nassour T, Thomasius F, et al
    The impact of depot medroxyprogesterone acetate on fracture risk: a case-control study from the UK.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  106. FOLBERT EC, Hegeman JH, Vermeer M, Regtuijt EM, et al
    Improved 1-year mortality in elderly patients with a hip fracture following integrated orthogeriatric treatment.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  107. MCCLOSKEY EV, Johansson H, Harvey NC, Compston J, et al
    Access to fracture risk assessment by FRAX and linked National Osteoporosis Guideline Group (NOGG) guidance in the UK-an analysis of anonymous website activity.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  108. WOZNIAK LA, Johnson JA, McAlister FA, Beaupre LA, et al
    Understanding fragility fracture patients' decision-making process regarding bisphosphonate treatment.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  109. GEDMINTAS L, Wright EA, Dong Y, Lehmann E, et al
    Factors associated with fractures in HIV-infected persons: which factors matter?
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  110. WEAVER CM, Dawson-Hughes B, Lappe JM, Wallace TC, et al
    Erratum and additional analyses re: Calcium plus vitamin D supplementation and the risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation.
    Osteoporos Int. 2016.
    PubMed     Text format    


  111. CHANG AJ, Ying Q, Chen XN, Wang WM, et al
    Evaluation of three risk assessment tools in discriminating fracture status among Chinese patients undergoing hemodialysis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  112. SENAY A, Delisle J, Giroux M, Laflamme GY, et al
    The impact of a standardized order set for the management of non-hip fragility fractures in a Fracture Liaison Service.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


    June 2016
  113. CHIANG JI, Li TC, Li CI, Liu CS, et al
    Visit-to-visit variation of fasting plasma glucose is a predictor of hip fracture in older persons with type 2 diabetes: the Taiwan Diabetes Study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  114. MACHADO LG, Domiciano DS, Figueiredo CP, Caparbo VF, et al
    Visceral fat measured by DXA is associated with increased risk of non-spine fractures in nonobese elderly women: a population-based prospective cohort analysis from the Sao Paulo Ageing & Health (SPAH) Study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  115. CHANG PY, Saechao FS, Lee J, Haskell SG, et al
    Prevalence and risk of fracture diagnoses in women across the adult life span: a national cross-sectional study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  116. TAKAHASHI S, Hoshino M, Takayama K, Iseki K, et al
    Predicting delayed union in osteoporotic vertebral fractures with consecutive magnetic resonance imaging in the acute phase: a multicenter cohort study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  117. KARAYIANNIS PN, McAlinden MG
    Falling age-related incidence of hip fractures in women, but not men, in Northern Ireland: 2001-2011.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  118. MARQUES EA, Gudnason V, Lang T, Sigurdsson G, et al
    Association of bone turnover markers with volumetric bone loss, periosteal apposition, and fracture risk in older men and women: the AGES-Reykjavik longitudinal study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  119. SHIN YH, Gong HS, Gang DH, Shin HS, et al
    Evaluation of trabecular bone score in patients with a distal radius fracture.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  120. CARRIERE I, Farre A, Norton J, Wyart M, et al
    Patterns of selective serotonin reuptake inhibitor use and risk of falls and fractures in community-dwelling elderly people: the Three-City cohort.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  121. PEREIRA RM, Figueiredo CP, Cha CC, Caparbo VF, et al
    Associations between OPG and RANKL polymorphisms, vertebral fractures, and abdominal aortic calcification in community-dwelling older subjects: the Sao Paulo Ageing & Health Study (SPAH).
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  122. LUCATO P, Trevisan C, Stubbs B, Zanforlini BM, et al
    Nephrolithiasis, bone mineral density, osteoporosis, and fractures: a systematic review and comparative meta-analysis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  123. VAN DER VELDE RY, Wyers CE, Curtis EM, Geusens PP, et al
    Secular trends in fracture incidence in the UK between 1990 and 2012.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  124. BALASUBRAMANIAN A, Wade SW, Adler RA, Lin CJ, et al
    Glucocorticoid exposure and fracture risk in patients with new-onset rheumatoid arthritis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  125. ZHOU J, Ma X, Wang T, Zhai S, et al
    Comparative efficacy of bisphosphonates in short-term fracture prevention for primary osteoporosis: a systematic review with network meta-analyses.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  126. AL-SARI UA, Tobias J, Clark E
    Health-related quality of life in older people with osteoporotic vertebral fractures: a systematic review and meta-analysis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


    May 2016
  127. ZHAO Y, Xue R, Shi N, Xue Y, et al
    Aggravation of spinal cord compromise following new osteoporotic vertebral compression fracture prevented by teriparatide in patients with surgical contraindications.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  128. LV H, Yin P, Long A, Gao Y, et al
    Clinical characteristics and risk factors of postoperative pneumonia after hip fracture surgery: a prospective cohort study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  129. SALE JE, Ashe MC, Beaton D, Bogoch E, et al
    Men's health-seeking behaviours regarding bone health after a fragility fracture: a secondary analysis of qualitative data.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  130. DE WAARD EA, Koster A, Melai T, van Geel TA, et al
    The association between glucose metabolism status, diabetes severity and a history of fractures and recent falls in participants of 50 years and older-the Maastricht Study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  131. BETHEL M, Weaver FM, Bailey L, Miskevics S, et al
    Risk factors for osteoporotic fractures in persons with spinal cord injuries and disorders.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  132. AXELSSON KF, Jacobsson R, Lund D, Lorentzon M, et al
    Effectiveness of a minimal resource fracture liaison service.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  133. SHIPMAN KE, Stammers J, Doyle A, Gittoes N, et al
    Delivering a quality-assured fracture liaison service in a UK teaching hospital-is it achievable?
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  134. LUAN L, Li R, Wang Z, Hou X, et al
    Stroke increases the risk of hip fracture: a systematic review and meta-analysis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  135. CHUNG SM, Hyun MH, Lee E, Seo HS, et al
    Novel effects of sarcopenic osteoarthritis on metabolic syndrome, insulin resistance, osteoporosis, and bone fracture: the national survey.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  136. VON FRIESENDORFF M, McGuigan FE, Wizert A, Rogmark C, et al
    Hip fracture, mortality risk, and cause of death over two decades.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  137. CHAN DC, Chang CH, Lim LC, Brnabic AJ, et al
    Association between teriparatide treatment persistence and adherence, and fracture incidence in Taiwan: analysis using the National Health Insurance Research Database.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  138. KEMMLER W, Bebenek M, Kohl M, von Stengel S, et al
    Possible different roles of exercise in preventing vertebral and hip fractures: response to comments by Sugiyama et al.
    Osteoporos Int. 2016.
    PubMed     Text format    


  139. SUGIYAMA T, Watarai K, Oda T, Kim YT, et al
    Possible different roles of exercise in preventing vertebral and hip fractures.
    Osteoporos Int. 2016.
    PubMed     Text format    


  140. CUNNINGHAM TD, Martin BC, DeShields SC, Romero CC, et al
    The impact of osteoporotic fractures compared with other health conditions in older adults living in Virginia, United States.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  141. CHOW SK, Leung KS, Qin J, Guo A, et al
    Mechanical stimulation enhanced estrogen receptor expression and callus formation in diaphyseal long bone fracture healing in ovariectomy-induced osteoporotic rats.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  142. HEILMEIER U, Cheng K, Pasco C, Parrish R, et al
    Cortical bone laminar analysis reveals increased midcortical and periosteal porosity in type 2 diabetic postmenopausal women with history of fragility fractures compared to fracture-free diabetics.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  143. MCCLUNG MR
    Cancel the denosumab holiday.
    Osteoporos Int. 2016;27:1677-82.
    PubMed     Text format    


  144. PAUPITZ JA, Lima GL, Alvarenga JC, Oliveira RM, et al
    Bone impairment assessed by HR-pQCT in juvenile-onset systemic lupus erythematosus.
    Osteoporos Int. 2016;27:1839-48.
    PubMed     Text format     Abstract available


  145. YAN L, He B, Guo H, Liu T, et al
    The prospective self-controlled study of unilateral transverse process-pedicle and bilateral puncture techniques in percutaneous kyphoplasty.
    Osteoporos Int. 2016;27:1849-55.
    PubMed     Text format     Abstract available


    April 2016
  146. ZHAO G, Liu X, Li F
    Balloon kyphoplasty versus percutaneous vertebroplasty for treatment of osteoporotic vertebral compression fractures (OVCFs).
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  147. BEAUDOIN C, Jean S, Bessette L, Ste-Marie LG, et al
    Denosumab compared to other treatments to prevent or treat osteoporosis in individuals at risk of fracture: a systematic review and meta-analysis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  148. SILVERMAN SL, Kupperman ES, Bukata SV
    Fracture healing: a consensus report from the International Osteoporosis Foundation Fracture Working Group.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  149. HA YC, Kim TY, Lee A, Lee YK, et al
    Current trends and future projections of hip fracture in South Korea using nationwide claims data.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  150. LESLIE WD, Majumdar SR, Lix LM, Josse RG, et al
    Direct comparison of FRAX and a simplified fracture risk assessment tool in routine clinical practice: a registry-based cohort study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  151. QASIM M, Farinella G, Zhang J, Li X, et al
    Patient-specific finite element estimated femur strength as a predictor of the risk of hip fracture: the effect of methodological determinants.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  152. PARK SM, Ryu J, Lee DR, Shin D, et al
    Zolpidem use and risk of fractures: a systematic review and meta-analysis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  153. YUAN ZC, Mo H, Guan J, He JL, et al
    Risk of hip fracture following stroke, a meta-analysis of 13 cohort studies.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  154. PEDERSEN AB, Cronin Fenton D, Norgaard M, Kristensen NR, et al
    Body mass index, risk of allogeneic red blood cell transfusion, and mortality in elderly patients undergoing hip fracture surgery.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  155. THORNE K, Johansen A, Akbari A, Williams JG, et al
    The impact of social deprivation on mortality following hip fracture in England and Wales: a record linkage study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  156. WALLACE IJ, Botigue LR, Lin M, Smaers JB, et al
    Worldwide variation in hip fracture incidence weakly aligns with genetic divergence between populations.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  157. CHOI HJ, Park C, Lee YK, Ha YC, et al
    Risk of fractures and diabetes medications: a nationwide cohort study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  158. HEANEY RP
    Achieving the protection of high peak bone mass.
    Osteoporos Int. 2016;27:1279-80.
    PubMed     Text format    


    March 2016
  159. FROST SA, Nguyen TV
    Uncertain effects of calcium and vitamin D supplementation on fracture risk reduction.
    Osteoporos Int. 2016.
    PubMed     Text format    


  160. BAE SJ, Lee SH, Ahn SH, Kim HM, et al
    The circulating sphingosine-1-phosphate level predicts incident fracture in postmenopausal women: a 3.5-year follow-up observation study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  161. EVSTIGNEEVA L, Lesnyak O, Bultink IE, Lems WF, et al
    Effect of twelve-month physical exercise program on patients with osteoporotic vertebral fractures: a randomized, controlled trial.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  162. PERRY BA, Archer KR, Song Y, Ma Y, et al
    Erratum to: Medication therapy for attention deficit/hyperactivity disorder is associated with lower risk of fracture: a retrospective cohort study.
    Osteoporos Int. 2016.
    PubMed     Text format    


  163. YIN P, Lv H, Zhang L, Long A, et al
    Combination of red cell distribution width and American Society of Anesthesiologists score for hip fracture mortality prediction.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  164. ROUX JP, Belghali S, Wegrzyn J, Rendu ES, et al
    Vertebral body morphology is associated with incident lumbar vertebral fracture in postmenopausal women. The OFELY study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  165. NAYLOR KL, Lix LM, Hans D, Garg AX, et al
    Trabecular bone score in kidney transplant recipients.
    Osteoporos Int. 2016;27:1115-21.
    PubMed     Text format     Abstract available


  166. MAMAN E, Borderie D, Roux C, Briot K, et al
    Absence of recognition of low alkaline phosphatase level in a tertiary care hospital.
    Osteoporos Int. 2016;27:1251-4.
    PubMed     Text format     Abstract available


    February 2016
  167. PERRY BA, Archer KR, Song Y, Ma Y, et al
    Medication therapy for attention deficit/hyperactivity disorder is associated with lower risk of fracture: a retrospective cohort study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  168. HOPKINS SJ, Toms AD, Brown M, Welsman JR, et al
    A study investigating short- and medium-term effects on function, bone mineral density and lean tissue mass post-total knee replacement in a Caucasian female post-menopausal population: implications for hip fracture risk.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  169. BYNUM JP, Bell JE, Cantu RV, Wang Q, et al
    Second fractures among older adults in the year following hip, shoulder, or wrist fracture.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  170. JURISSON M, Pisarev H, Kanis J, Borgstrom F, et al
    Quality of life, resource use, and costs related to hip fracture in Estonia.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  171. EL-HAJ M, Gurt I, Cohen-Kfir E, Dixit V, et al
    Reduced Sirtuin1 expression at the femoral neck in women who sustained an osteoporotic hip fracture.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  172. SOGAARD AJ, Holvik K, Meyer HE, Tell GS, et al
    Continued decline in hip fracture incidence in Norway: a NOREPOS study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  173. DELESKOG L, Laursen NO, Nielsen BR, Schwarz P, et al
    Vertebral fracture assessment by DXA is inferior to X-ray in clinical severe osteoporosis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  174. SUGIYAMA T, Watarai K, Oda T, Kim YT, et al
    Proton pump inhibitors and fracture: they impair bone quality and increase fall risk?
    Osteoporos Int. 2016.
    PubMed     Text format    


  175. NORIEGA DC, Ramajo RH, Lite IS, Toribio B, et al
    Safety and clinical performance of kyphoplasty and SpineJack procedures in the treatment of osteoporotic vertebral compression fractures: a pilot, monocentric, investigator-initiated study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  176. WEAVER CM, Gordon CM, Janz KF, Kalkwarf HJ, et al
    The National Osteoporosis Foundation's position statement on peak bone mass development and lifestyle factors: a systematic review and implementation recommendations.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  177. MEYER HE, Willett WC, Flint AJ, Feskanich D, et al
    Abdominal obesity and hip fracture: results from the Nurses' Health Study and the Health Professionals Follow-up Study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  178. HAGEN G, Wisloff T, Kristiansen IS
    The predicted lifetime costs and health consequences of calcium and vitamin D supplementation for fracture prevention-the impact of cardiovascular effects.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  179. DRIESSEN JH, Hansen L, Eriksen SA, van Onzenoort HA, et al
    The epidemiology of fractures in Denmark in 2011.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  180. UZOIGWE OF
    Proton pump inhibitors and fracture: do they do what it says on the tin?
    Osteoporos Int. 2016.
    PubMed     Text format    


    January 2016
  181. BURGERS PT, Hoogendoorn M, Van Woensel EA, Poolman RW, et al
    Total medical costs of treating femoral neck fracture patients with hemi- or total hip arthroplasty: a cost analysis of a multicenter prospective study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  182. PAPAIOANNOU A, Kennedy CC, Ioannidis G, Cameron C, et al
    Comparative trends in incident fracture rates for all long-term care and community-dwelling seniors in Ontario, Canada, 2002-2012.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  183. PIOLI G, Lauretani F, Pellicciotti F, Pignedoli P, et al
    Modifiable and non-modifiable risk factors affecting walking recovery after hip fracture.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  184. PEDERSEN AB, Baggesen LM, Ehrenstein V, Pedersen L, et al
    Perceived stress and risk of any osteoporotic fracture.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  185. KATZMAN WB, Vittinghoff E, Kado DM, Lane NE, et al
    Thoracic kyphosis and rate of incident vertebral fractures: the Fracture Intervention Trial.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  186. AMICHE MA, Albaum JM, Tadrous M, Pechlivanoglou P, et al
    Efficacy of osteoporosis pharmacotherapies in preventing fracture among oral glucocorticoid users: a network meta-analysis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  187. LEE JH, Lee YK, Oh SH, Ahn J, et al
    A systematic review of diagnostic accuracy of vertebral fracture assessment (VFA) in postmenopausal women and elderly men.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  188. DREW S, Judge A, Cooper C, Javaid MK, et al
    Secondary prevention of fractures after hip fracture: a qualitative study of effective service delivery.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  189. WANG X, Yan S, Liu C, Xu Y, et al
    Fracture risk and bone mineral density levels in patients with systemic lupus erythematosus: a systematic review and meta-analysis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  190. ORIMO H, Yaegashi Y, Hosoi T, Fukushima Y, et al
    Hip fracture incidence in Japan: Estimates of new patients in 2012 and 25-year trends.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  191. BLIEMEL C, Sielski R, Doering B, Dodel R, et al
    Pre-fracture quality of life predicts 1-year survival in elderly patients with hip fracture-development of a new scoring system.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  192. LESLIE WD, Schousboe JT, Lix LM
    Towards better use of the net reclassification improvement (NRI) index.
    Osteoporos Int. 2016;27:411-2.
    PubMed     Text format    


  193. LEIB ES, Winzenrieth R
    Bone status in glucocorticoid-treated men and women.
    Osteoporos Int. 2016;27:39-48.
    PubMed     Text format     Abstract available


  194. NEUMANN T, Lodes S, Kastner B, Lehmann T, et al
    Trabecular bone score in type 1 diabetes--a cross-sectional study.
    Osteoporos Int. 2016;27:127-33.
    PubMed     Text format     Abstract available


  195. OTAIFY GA, Aglan MS, Ibrahim MM, Elnashar M, et al
    Zoledronic acid in children with osteogenesis imperfecta and Bruck syndrome: a 2-year prospective observational study.
    Osteoporos Int. 2016;27:81-92.
    PubMed     Text format     Abstract available


  196. HARVEY NC, Johansson H, Oden A, Karlsson MK, et al
    FRAX predicts incident falls in elderly men: findings from MrOs Sweden.
    Osteoporos Int. 2016;27:267-74.
    PubMed     Text format     Abstract available


    December 2015
  197. POPP AW, Zysset PK, Lippuner K
    Rebound-associated vertebral fractures after discontinuation of denosumab-from clinic and biomechanics.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  198. AMICHE MA, Albaum JM, Tadrous M, Pechlivanoglou P, et al
    Fracture risk in oral glucocorticoid users: a Bayesian meta-regression leveraging control arms of osteoporosis clinical trials.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  199. ANASTASILAKIS AD, Makras P
    Multiple clinical vertebral fractures following denosumab discontinuation.
    Osteoporos Int. 2015.
    PubMed     Text format    


  200. SILVERMAN SL, Adachi JD, Dennison E
    Bisphosphonate drug holidays: we reap what we sow.
    Osteoporos Int. 2015.
    PubMed     Text format    


  201. KRUSE C, Eiken P, Vestergaard P
    Optimal age of commencing and discontinuing thiazide therapy to protect against fractures.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  202. SVENSSON HK, Olofsson EH, Karlsson J, Hansson T, et al
    A painful, never ending story: older women's experiences of living with an osteoporotic vertebral compression fracture.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  203. BETHEL M, Buzkova P, Fink HA, Robbins JA, et al
    Soluble CD14 and fracture risk.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  204. NAKAYAMA A, Major G, Holliday E, Attia J, et al
    Evidence of effectiveness of a fracture liaison service to reduce the re-fracture rate.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  205. XU LH, Adams-Huet B, Poindexter JR, Maalouf NM, et al
    Determinants of change in bone mineral density and fracture risk during bisphosphonate holiday.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  206. BOURS S, de Vries F, van den Bergh JP, Lalmohamed A, et al
    Risk of vertebral and non-vertebral fractures in patients with sarcoidosis: a population-based cohort.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  207. RUDANG R, Zoulakis M, Sundh D, Brisby H, et al
    Bone material strength is associated with areal BMD but not with prevalent fractures in older women.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  208. FINNES TE, Lofthus CM, Meyer HE, Sogaard AJ, et al
    A combination of low serum concentrations of vitamins K and D is associated with increased risk of hip fractures in elderly Norwegians: a NOREPOS study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


    November 2015
  209. ZHOU B, Huang Y, Li H, Sun W, et al
    Proton pump inhibitors and fracture risk: response to comments.
    Osteoporos Int. 2015.
    PubMed     Text format    


  210. SENAY A, Delisle J, Raynauld JP, Morin SN, et al
    Agreement between physicians' and nurses' clinical decisions for the management of the fracture liaison service (4iFLS): the Lucky Bone program.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  211. MARAVIC M, Ostertag A, Urena P, Cohen-Solal M, et al
    Dementia is a major risk factor for hip fractures in patients with chronic kidney disease.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  212. BROZEK W, Reichardt B, Zwerina J, Dimai HP, et al
    Antiresorptive therapy and risk of mortality and refracture in osteoporosis-related hip fracture: a nationwide study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  213. MADSEN CM, Jantzen C, Lauritzen JB, Abrahamsen B, et al
    Hyponatremia and hypernatremia are associated with increased 30-day mortality in hip fracture patients.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  214. AVILA ML, Pullenayegum E, Williams S, Shammas A, et al
    Timing of low bone mineral density and predictors of bone mineral density trajectory in children on long-term warfarin: a longitudinal study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  215. CLARK EM, Gooberman-Hill R, Peters TJ
    Using self-reports of pain and other variables to distinguish between older women with back pain due to vertebral fractures and those with back pain due to degenerative changes.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  216. UZOIGWE CE
    The real enemy is fragility fracture, not osteoporosis.
    Osteoporos Int. 2015.
    PubMed     Text format    


  217. MCCLOSKEY E
    A BMD threshold for treatment efficacy in osteoporosis? A need to consider the whole evidence base.
    Osteoporos Int. 2015.
    PubMed     Text format    


  218. FARSINEJAD-MARJ M, Saneei P, Esmaillzadeh A
    Dietary magnesium intake, bone mineral density and risk of fracture: a systematic review and meta-analysis.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  219. MURRAY JC, Audet MC, Bedard M, Michou L, et al
    Bilateral distal fibula fractures in a woman on long-term bisphosphonate therapy.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  220. BEALL DP, Feldman RG, Gordon ML, Gruber BL, et al
    Patients with prior vertebral or hip fractures treated with teriparatide in the Direct Assessment of Nonvertebral Fractures in Community Experience (DANCE) observational study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  221. SUGIYAMA T, Torio T, Miyajima T, Kim YT, et al
    Calcium, proton pump inhibitors, and fracture risk.
    Osteoporos Int. 2015.
    PubMed     Text format    


  222. RUD B, Vestergaard A, Hyldstrup L
    Accuracy of densitometric vertebral fracture assessment when performed by DXA technicians-a cross-sectional, multiobserver study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  223. CHEN F, Dai Z, Kang Y, Lv G, et al
    Effects of zoledronic acid on bone fusion in osteoporotic patients after lumbar fusion.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  224. WIKLUND R, Toots A, Conradsson M, Olofsson B, et al
    Risk factors for hip fracture in very old people: a population-based study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


    October 2015
  225. JACOB L, Dreher M, Kostev K, Hadji P, et al
    Increased treatment persistence and its determinants in women with osteoporosis with prior fracture compared to those without fracture.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  226. SATO H, Kondo N, Wada Y, Nakatsue T, et al
    The cumulative incidence of and risk factors for latent beaking in patients with autoimmune diseases taking long-term glucocorticoids and bisphosphonates.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  227. WEAVER CM, Alexander DD, Boushey CJ, Dawson-Hughes B, et al
    Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  228. DARUWALLA ZJ, Huq SS, Wong KL, Nee PY, et al
    Hip fractures, preceding distal radius fractures and screening for osteoporosis: should we be screening earlier? A minimum 10-year retrospective cohort study at a single centre.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  229. AUBRY-ROZIER B, Gonzalez-Rodriguez E, Stoll D, Lamy O, et al
    Severe spontaneous vertebral fractures after denosumab discontinuation: three case reports.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  230. MEMETOGLU OG, Ozkan FU, Boy NS, Aktas I, et al
    Sacroiliitis or insufficiency fracture?
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  231. NAZARZADEH M, Bidel Z, Sanjari Moghaddam A
    Meta-analysis of diabetes mellitus and risk of hip fractures: small-study effect.
    Osteoporos Int. 2015.
    PubMed     Text format    


  232. SELGA J, Nunez JH, Minguell J, Lalanza M, et al
    Simultaneous bilateral atypical femoral fracture in a patient receiving denosumab: case report and literature review.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  233. HOLM JP, Amar AO, Hyldstrup L, Jensen JE, et al
    Hyponatremia, a risk factor for osteoporosis and fractures in women.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  234. SUGIYAMA T, Kim YT, Oda H
    Both falling and bone fragility should be targeted to prevent hip fracture in older adults.
    Osteoporos Int. 2015.
    PubMed     Text format    


  235. EBINA K, Noguchi T, Hirao M, Hashimoto J, et al
    Effects of switching weekly alendronate or risedronate to monthly minodronate in patients with rheumatoid arthritis: a 12-month prospective study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  236. ZHOU B, Huang Y, Li H, Sun W, et al
    Proton-pump inhibitors and risk of fractures: an update meta-analysis.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  237. RAMCHAND SK, Chiang CY, Zebaze RM, Seeman E, et al
    Recurrence of bilateral atypical femoral fractures associated with the sequential use of teriparatide and denosumab: a case report.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  238. FINK HA, Litwack-Harrison S, Taylor BC, Bauer DC, et al
    Clinical utility of routine laboratory testing to identify possible secondary causes in older men with osteoporosis: the Osteoporotic Fractures in Men (MrOS) Study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  239. WANG Q, Huang Q, Zeng Y, Liang JJ, et al
    Parity and osteoporotic fracture risk in postmenopausal women: a dose-response meta-analysis of prospective studies.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  240. HOLLOWAY KL, Henry MJ, Brennan-Olsen SL, Bucki-Smith G, et al
    Non-hip and non-vertebral fractures: the neglected fracture sites.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


    September 2015
  241. HEGDE V, Jo JE, Andreopoulou P, Lane JM, et al
    Effect of osteoporosis medications on fracture healing.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  242. LEE SJ, Binkley N, Lubner MG, Bruce RJ, et al
    Opportunistic screening for osteoporosis using the sagittal reconstruction from routine abdominal CT for combined assessment of vertebral fractures and density.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  243. MUSEYKO O, Bousson V, Adams J, Laredo J-, et al
    QCT of the proximal femur-which parameters should be measured to discriminate hip fracture?
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  244. BLACKBURN J, Locher JL, Morrisey MA, Becker DJ, et al
    The effects of state-level expenditures for home- and community-based services on the risk of becoming a long-stay nursing home resident after hip fracture.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  245. ETHGEN O, Hiligsmann M, Burlet N, Reginster JY, et al
    Cost-effectiveness of personalized supplementation with vitamin D-rich dairy products in the prevention of osteoporotic fractures.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  246. HWANG IR, Choi YK, Lee WK, Kim JG, et al
    Association between prolonged breastfeeding and bone mineral density and osteoporosis in postmenopausal women: KNHANES 2010-2011.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  247. THINGSTAD P, Taraldsen K, Saltvedt I, Sletvold O, et al
    The long-term effect of comprehensive geriatric care on gait after hip fracture: the Trondheim Hip Fracture Trial-a randomised controlled trial.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  248. LUO Y
    A biomechanical sorting of clinical risk factors affecting osteoporotic hip fracture.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  249. FRITZ J, Coster ME, Nilsson JA, Rosengren BE, et al
    The associations of physical activity with fracture risk-a 7-year prospective controlled intervention study in 3534 children.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  250. BONE HG, Dempster DW, Eisman JA, Greenspan SL, et al
    Erratum to: Odanacatib for the treatment of postmenopausal osteoporosis: development history and design and participant characteristics of LOFT, the Long-Term Odanacatib Fracture Trial.
    Osteoporos Int. 2015.
    PubMed     Text format    


  251. LANDEIRO F, Leal J, Gray AM
    The impact of social isolation on delayed hospital discharges of older hip fracture patients and associated costs.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  252. CARBONE S, Papalia M
    The amount of impaction and loss of reduction in osteoporotic proximal humeral fractures after surgical fixation.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


    August 2015
  253. LOPEZ-DE-ANDRES A, Jimenez-Garcia R, Jimenez-Trujillo I, Hernandez-Barrera V, et al
    Incidence, surgical procedures, and outcomes of hip fracture among elderly type 2 diabetic and non-diabetic patients in Spain (2004-2013).
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  254. THORIN MH, Wihlborg A, Akesson K, Gerdhem P, et al
    Smoking, smoking cessation, and fracture risk in elderly women followed for 10 years.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  255. SCAGLIONE M, Fabbri L, Casella F, Guido G, et al
    Strontium ranelate as an adjuvant for fracture healing: clinical, radiological, and ultrasound findings in a randomized controlled study on wrist fractures.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  256. EDWARDS BJ, Gradishar WJ, Smith ME, Pacheco JA, et al
    Elevated incidence of fractures in women with invasive breast cancer.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  257. MOON RJ, Lim A, Farmer M, Segaran A, et al
    Validity of parental recall of children's fracture: implications for investigation of childhood osteoporosis.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  258. LEAL J, Gray AM, Prieto-Alhambra D, Arden NK, et al
    Impact of hip fracture on hospital care costs: a population-based study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  259. HOLZMUELLER CG, Karp S, Zeldow D, Lee DB, et al
    Development of a cloud-based application for the Fracture Liaison Service model of care.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  260. KHOO BC, Lewis JR, Brown K, Prince RL, et al
    Evaluation of a simplified hip structure analysis method for the prediction of incident hip fracture events.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  261. YONG JH, Masucci L, Hoch JS, Sujic R, et al
    Cost-effectiveness of a fracture liaison service-a real-world evaluation after 6 years of service provision.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  262. FECHTENBAUM J, Etcheto A, Kolta S, Feydy A, et al
    Sagittal balance of the spine in patients with osteoporotic vertebral fractures.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  263. BARZILAY JI, Buzkova P, Kizer JR, Djousse L, et al
    Fibrosis markers, hip fracture risk, and bone density in older adults.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  264. TIAN M, Gong X, Rath S, Wei J, et al
    Management of hip fractures in older people in Beijing: a retrospective audit and comparison with evidence-based guidelines and practice in the UK.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  265. FAN Y, Wei F, Lang Y, Liu Y, et al
    Diabetes mellitus and risk of hip fractures: a meta-analysis.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  266. ORIVE M, Anton-Ladislao A, Garcia-Gutierrez S, Las Hayas C, et al
    Prospective study of predictive factors of changes in pain and hip function after hip fracture among the elderly.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  267. LESLIE WD, Brennan-Olsen SL, Morin SN, Lix LM, et al
    Fracture prediction from repeat BMD measurements in clinical practice.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  268. CHANG CY, Tang CH, Chen KC, Huang KC, et al
    The mortality and direct medical costs of osteoporotic fractures among postmenopausal women in Taiwan.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


    July 2015
  269. YAN Z, Huang H, Li J, Wang J, et al
    Relationship between subclinical thyroid dysfunction and the risk of fracture: a meta-analysis of prospective cohort studies.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  270. PLUSKIEWICZ W, Adamczyk P, Czekajlo A, Grzeszczak W, et al
    Erratum to: High fracture probability predicts fractures in a 4-year follow-up in women from the RAC-OST-POL study.
    Osteoporos Int. 2015.
    PubMed     Text format    


  271. HA KY, Park KS, Kim SI, Kim YH, et al
    Does bisphosphonate-based anti-osteoporosis medication affect osteoporotic spinal fracture healing?
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  272. PAPAPOULOS S, Lippuner K, Roux C, Lin CJ, et al
    The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  273. ZHUKOUSKAYA VV, Eller-Vainicher C, Gaudio A, Privitera F, et al
    Erratum to: The utility of lumbar spine trabecular bone score and femoral neck bone mineral density for identifying asymptomatic vertebral fractures in well-compensated type 2 diabetic patients.
    Osteoporos Int. 2015.
    PubMed     Text format    


  274. LING Y, Gao X, Lin H, Ma H, et al
    A common polymorphism rs1800247 in osteocalcin gene was associated with serum osteocalcin levels, bone mineral density, and fracture: the Shanghai Changfeng Study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  275. PLUSKIEWICZ W, Adamczyk P, Czekajlo A, Grzeszczak W, et al
    High fracture probability predicts fractures in a 4-year follow-up in women from the RAC-OST-POL study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  276. DAVEY T, Lanham-New SA, Shaw AM, Hale B, et al
    Low serum 25-hydroxyvitamin D is associated with increased risk of stress fracture during Royal Marine recruit training.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  277. ZHUKOUSKAYA VV, Vainicher CE, Gaudio A, Privitera F, et al
    The utility of lumbar spine trabecular bone score and femoral neck bone mineral density for identifying asymptomatic vertebral fractures in well-compensated type 2 diabetic patients.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  278. ALBAUM JM, Levesque LE, Gershon AS, Liu G, et al
    Glucocorticoid-induced osteoporosis management among seniors, by year, sex, and indication, 1996-2012.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  279. COMPSTON J
    Overdiagnosis of osteoporosis: fact or fallacy?
    Osteoporos Int. 2015.
    PubMed     Text format    


  280. WANG CY, Fu SH, Wang CL, Chen PJ, et al
    Serotonergic antidepressant use and the risk of fracture: a population-based nested case-control study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


    June 2015
  281. SALE JE, Gignac MA, Hawker G, Beaton D, et al
    Patients do not have a consistent understanding of high risk for future fracture: a qualitative study of patients from a post-fracture secondary prevention program.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  282. AMOUZOUGAN A, Deygat A, Trombert B, Constant E, et al
    Spectacular improvement in vitamin D status in elderly osteoporotic women: 8-year analysis of an osteoporotic population treated in a dedicated fracture liaison service.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  283. HERNANDEZ I, Pinera A
    Incidence of fracture events with teriparatide: role of study design.
    Osteoporos Int. 2015.
    PubMed     Text format    


  284. HARVEY NC, Kanis JA, Oden A, Burge RT, et al
    FRAX and the effect of teriparatide on vertebral and non-vertebral fracture.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  285. HARVEY NC, Kanis JA, Oden A, Nakamura T, et al
    Efficacy of weekly teriparatide does not vary by baseline fracture probability calculated using FRAX.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  286. JAVAID MK, Kyer C, Mitchell PJ, Chana J, et al
    Effective secondary fracture prevention: implementation of a global benchmarking of clinical quality using the IOF Capture the Fracture(R) Best Practice Framework tool.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  287. FERRARI S, Adachi JD, Lippuner K, Zapalowski C, et al
    Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 years.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  288. BRIOT K, Fechtenbaum J, Etcheto A, Kolta S, et al
    Diagnosis of vertebral fractures using a low-dose biplanar imaging system.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  289. NARANJO A, Ojeda-Bruno S, Bilbao-Cantarero A, Quevedo-Abeledo JC, et al
    Two-year adherence to treatment and associated factors in a fracture liaison service in Spain.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  290. GUO Z, Yang J, Zheng Y, Wang Y, et al
    Thoracolumbar fascia injury associated with residual back pain after percutaneous vertebroplasty: a compelling study.
    Osteoporos Int. 2015.
    PubMed     Text format    


  291. HASHEM J, Krochak R, Culbertson MD, Mileto C, et al
    Atypical femur fractures in a patient with pycnodysostosis: a case report.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  292. YAN Y, Zou T, Xu R
    Reply to "Thoracolumbar fascia injury associated with residual back pain after percutaneous vertebroplasty: a compelling study".
    Osteoporos Int. 2015.
    PubMed     Text format    


    May 2015
  293. ODEN A, McCloskey EV, Kanis JA, Harvey NC, et al
    Burden of high fracture probability worldwide: secular increases 2010-2040.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  294. HADJI P, Papaioannou N, Gielen E, Feudjo Tepie M, et al
    Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a European non-interventional study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  295. CROCKETT K, Arnold CM, Farthing JP, Chilibeck PD, et al
    Bone strength and muscle properties in postmenopausal women with and without a recent distal radius fracture.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  296. NAKAMURA T, Ito M, Hashimoto J, Shinomiya K, et al
    Clinical efficacy and safety of monthly oral ibandronate 100 mg versus monthly intravenous ibandronate 1 mg in Japanese patients with primary osteoporosis.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  297. WU CT, Yang YH, Chen PC, Chen MF, et al
    Androgen deprivation increases the risk of fracture in prostate cancer patients: a population-based study in Chinese patients.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  298. MARQUES A, Lourenco O, da Silva JA
    The burden of osteoporotic hip fractures in Portugal: costs, health related quality of life and mortality.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  299. FREEDBERG DE, Haynes K, Denburg MR, Zemel BS, et al
    Use of proton pump inhibitors is associated with fractures in young adults: a population-based study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  300. SABHARWAL S, Wilson H
    Orthogeriatrics in the management of frail older patients with a fragility fracture.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  301. TSUKUTANI Y, Hagino H, Ito Y, Nagashima H, et al
    Epidemiology of fragility fractures in Sakaiminato, Japan: incidence, secular trends, and prognosis.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  302. WANG O, Hu Y, Gong S, Xue Q, et al
    A survey of outcomes and management of patients post fragility fractures in China.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  303. KEMMLER W, Bebenek M, Kohl M, von Stengel S, et al
    Exercise and fractures in postmenopausal women. Final results of the controlled Erlangen Fitness and Osteoporosis Prevention Study (EFOPS).
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  304. KLOP C, Gibson-Smith D, Elders PJ, Welsing PM, et al
    Anti-osteoporosis drug prescribing after hip fracture in the UK: 2000-2010.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  305. YOUN JC, Lee SJ, Lee HS, Oh J, et al
    Exercise capacity independently predicts bone mineral density and proximal femoral geometry in patients with acute decompensated heart failure.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  306. MIYAKOSHI N, Hongo M, Kobayashi T, Abe T, et al
    Improvement of spinal alignment and quality of life after corrective surgery for spinal kyphosis in patients with osteoporosis: a comparative study with non-operated patients.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  307. CIZMIC AD, Heilmann RM, Milchak JL, Riggs CS, et al
    Impact of interactive voice response technology on primary adherence to bisphosphonate therapy: a randomized controlled trial.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  308. CHEN L, Wang G, Zheng F, Zhao H, et al
    Efficacy of bisphosphonates against osteoporosis in adult men: a meta-analysis of randomized controlled trials.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  309. KOVACS CS, Ralston SH
    Presentation and management of osteoporosis presenting in association with pregnancy or lactation.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  310. SCILLITANI A, Mazziotti G, Di Somma C, Moretti S, et al
    Cortisol and the muscle-bone axis: response to comments by Molfino et al.
    Osteoporos Int. 2015;26:1661-2.
    PubMed     Text format    


    April 2015
  311. MOON RJ, Harvey NC, Davies JH, Cooper C, et al
    Vitamin D and bone development.
    Osteoporos Int. 2015;26:1449-51.
    PubMed     Text format    


  312. SUGIYAMA T, Yoshioka H, Sakaguchi K, Kim YT, et al
    An evidence-based perspective on vitamin D and the growing skeleton.
    Osteoporos Int. 2015;26:1447-8.
    PubMed     Text format    


  313. STOLLENWERK B, Bartmus T, Klug F, Stock S, et al
    Cost-effectiveness of hip protector use on a geriatric ward in Germany: a Markov model.
    Osteoporos Int. 2015;26:1367-79.
    PubMed     Text format     Abstract available


  314. BORGSTROM F, Beall DP, Berven S, Boonen S, et al
    Health economic aspects of vertebral augmentation procedures.
    Osteoporos Int. 2015;26:1239-49.
    PubMed     Text format     Abstract available


    March 2015
  315. CLAESSON A, Toth-Pal E, Piispanen P, Salminen H, et al
    District nurses' perceptions of osteoporosis management: a qualitative study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  316. HANDS B, Chivers P, McIntyre F, Bervenotti FC, et al
    Peripheral quantitative computed tomography (pQCT) reveals low bone mineral density in adolescents with motor difficulties.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  317. MAKRAS P, Athanasakis K, Boubouchairopoulou N, Rizou S, et al
    Cost-effective osteoporosis treatment thresholds in Greece.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  318. DAMJI AN, Bies K, Alibhai SM, Jones JM, et al
    Bone health management in men undergoing ADT: examining enablers and barriers to care.
    Osteoporos Int. 2015;26:951-9.
    PubMed     Text format     Abstract available


  319. RUSSELL M, Clapperton A, Vu T, Day L, et al
    Trends in fall-related hospitalisations in older people living in aged care facilities.
    Osteoporos Int. 2015;26:1219-24.
    PubMed     Text format     Abstract available


    January 2015
  320. BANSAL S, Pecina JL, Merry SP, Kennel KA, et al
    US Preventative Services Task Force FRAX threshold has a low sensitivity to detect osteoporosis in women ages 50-64 years.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  321. MCCLUNG MR
    Bisphosphonate therapy: how long is long enough?
    Osteoporos Int. 2015.
    PubMed     Text format    


  322. MACHADO KL, Domiciano DS, Machado LG, Lopes JB, et al
    Persistent hypovitaminosis D and loss of hip bone mineral density over time as additional risk factors for recurrent falls in a population-based prospective cohort of elderly persons living in the community. The Sao Paulo Ageing & Health (SPAH) St
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  323. SI L, Winzenberg TM, Jiang Q, Palmer AJ, et al
    Screening for and treatment of osteoporosis: construction and validation of a state-transition microsimulation cost-effectiveness model.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  324. STUCKEY BG, Sallie R
    Alendronate-induced unmasking or deterioration of coeliac disease: a case series.
    Osteoporos Int. 2015;26:411-4.
    PubMed     Text format    


  325. ZHU TY, Griffith JF, Qin L, Hung VW, et al
    Density, structure, and strength of the distal radius in patients with psoriatic arthritis: the role of inflammation and cardiovascular risk factors.
    Osteoporos Int. 2015;26:261-72.
    PubMed     Text format     Abstract available


  326. CHOI WJ, Cripton PA, Robinovitch SN
    Effects of hip abductor muscle forces and knee boundary conditions on femoral neck stresses during simulated falls.
    Osteoporos Int. 2015;26:291-301.
    PubMed     Text format     Abstract available


    December 2014
  327. HUANG ZB, Wan SL, Lu YJ, Ning L, et al
    Does vitamin K2 play a role in the prevention and treatment of osteoporosis for postmenopausal women: a meta-analysis of randomized controlled trials.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


  328. YAN Y, Xu R, Zou T
    Is thoracolumbar fascia injury the cause of residual back pain after percutaneous vertebroplasty? A prospective cohort study.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


  329. OHTA H, Solanki J
    Incorporating bazedoxifene into the treatment paradigm for postmenopausal osteoporosis in Japan.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


    November 2014
  330. OLENGINSKI TP, Maloney-Saxon G, Matzko CK, Mackiewicz K, et al
    High-risk osteoporosis clinic (HiROC): improving osteoporosis and postfracture care with an organized, programmatic approach.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


    October 2014
  331. SHELTAWY AA, Criseno S, Gittoes NJ, Crowley RK, et al
    Fear of medication side effects is a barrier to optimal osteoporosis care.
    Osteoporos Int. 2014.
    PubMed     Text format    


  332. STROM O, Landfeldt E, Garellick G
    Residual effect after oral bisphosphonate treatment and healthy adherer effects-the Swedish adherence register analysis (SARA).
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


    September 2014
  333. SILVERMAN SL, Siris E, Kendler DL, Belazi D, et al
    Persistence at 12 months with denosumab in postmenopausal women with osteoporosis: interim results from a prospective observational study.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


  334. KANIS JA, McCloskey E, Branco J, Brandi ML, et al
    Goal-directed treatment of osteoporosis in Europe.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


  335. MOLFINO A, Aversa Z, Muscaritoli M
    Cortisol and the muscle-bone axis.
    Osteoporos Int. 2014;25:2331-2.
    PubMed     Text format    


  336. DAVIE MW
    Identifying coeliac disease in DXA referrals.
    Osteoporos Int. 2014;25:2329.
    PubMed     Text format    


    August 2014
  337. IKI M, Tamaki J, Sato Y, Winzenrieth R, et al
    Age-related normative values of trabecular bone score (TBS) for Japanese women: the Japanese Population-based Osteoporosis (JPOS) study.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


  338. LU Y, Krause M, Bishop N, Sellenschloh K, et al
    The role of patient-mode high-resolution peripheral quantitative computed tomography indices in the prediction of failure strength of the elderly women's thoracic vertebral body.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


  339. COSMAN F, de Beur SJ, LeBoff MS, Lewiecki EM, et al
    Clinician's Guide to Prevention and Treatment of Osteoporosis.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


    July 2014
  340. OH JH, Song BW, Kim SH, Choi JA, et al
    The measurement of bone mineral density of bilateral proximal humeri using DXA in patients with unilateral rotator cuff tear.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


  341. RIZZOLI R, Branco J, Brandi ML, Boonen S, et al
    Management of osteoporosis of the oldest old.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


  342. KYVERNITAKIS I, Kostev K, Kurth A, Albert US, et al
    Differences in persistency with teriparatide in patients with osteoporosis according to gender and health care provider.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


    June 2014
  343. CUNNINGHAM TD, Di Pace BS, Ullal J
    Osteoporosis treatment disparities: a 6-year aggregate analysis from national survey data.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


    March 2014
  344. PRENTICE RL, Jackson RD, Pettinger M, Rossouw JE, et al
    Incidence of milk alkali syndrome in the Women's Health Initiative clinical trial and cohort study: response to Neupane.
    Osteoporos Int. 2014;25:1195.
    PubMed     Text format    


  345. NEUPANE S
    Incidence of milk alkali syndrome in the Women's Health Initiative clinical trial and cohort study.
    Osteoporos Int. 2014;25:1193.
    PubMed     Text format    


    February 2014
  346. SCILLITANI A, Mazziotti G, Di Somma C, Moretti S, et al
    Treatment of skeletal impairment in patients with endogenous hypercortisolism: when and how?
    Osteoporos Int. 2014;25:441-6.
    PubMed     Text format     Abstract available


  347. HAGE MP, El-Hajj Fuleihan G
    Bone and mineral metabolism in patients undergoing Roux-en-Y gastric bypass.
    Osteoporos Int. 2014;25:423-39.
    PubMed     Text format     Abstract available


  348. PHAN V, Blydt-Hansen T, Feber J, Alos N, et al
    Skeletal findings in the first 12 months following initiation of glucocorticoid therapy for pediatric nephrotic syndrome.
    Osteoporos Int. 2014;25:627-37.
    PubMed     Text format     Abstract available


  349. CHEN CK, Chang HT, Chou HP, Lee MH, et al
    Alendronate and risk of lower limb ischemic vascular events: a population-based cohort study.
    Osteoporos Int. 2014;25:673-80.
    PubMed     Text format     Abstract available


    August 2013
  350. NAEGELI AN , Nixon A, Burge R, Gold DT, et al
    Development of the osteoporosis assessment questionnaire-physical function (OPAQ-PF): an osteoporosis-targeted, patient-reported outcomes (PRO) measure of physical function.
    Osteoporos Int. 2013.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Fractures is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: